Crizotinib 250 mg (Generic)

What is Crizotinib 250 mg?

Crizotinib 250 mg is a targeted anticancer medication used primarily in the treatment of non-small cell lung cancer (NSCLC). It contains the active ingredient Crizotinib, which is a novel kinase inhibitor designed to interrupt cancer cell growth. Manufactured by Pfizer India Ltd, this medication is renowned for its efficacy and safety profile in oncology treatments.

This medicine specifically treats certain types of lung cancer that express changes in particular genes affecting cellular proliferation. By inhibiting abnormal proteins, Crizotinib 250 mg can help slow down or stop the progression of tumors in patients diagnosed with NSCLC.

Each 250 mg tablet is formulated to deliver a precise dose suitable for daily oral administration under strict medical supervision. This ensures optimal therapeutic benefit while minimizing potential adverse effects. Proper use according to physician guidance is essential for achieving the desired treatment outcomes.

Patients diagnosed with advanced or metastatic NSCLC with specific genetic markers are often considered for treatment with Crizotinib 250 mg as a part of their oncology care regimen. Consultation with healthcare professionals is necessary to establish suitability and monitor treatment response.

Uses of Crizotinib 250 mg

• Treatment of non-small cell lung cancer (NSCLC) with ALK-positive or ROS1-positive genetic mutations
• Managing advanced or metastatic NSCLC in eligible patients
• Slowing down the progression of cancer cells in targeted gene-expressing tumors
• Used as monotherapy or part of combination therapy as prescribed

How Crizotinib 250 mg Works

Crizotinib 250 mg works by selectively inhibiting specific receptor tyrosine kinases, such as ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1). These kinases are involved in the signaling pathways that regulate cell growth and survival. In certain lung cancers, changes in these kinases result in uncontrolled cell division.

By blocking ALK and ROS1 activity, Crizotinib 250 mg interferes with the cancer cells’ ability to multiply and survive, leading to reduced tumor size and slowed disease progression. This targeted mechanism helps preserve healthy cells while maximizing cancer cell death.

The medication's selective action makes it a valuable option for patients with tumors that are driven by these particular genetic abnormalities. The precise targeting reduces damage to normal cells and limits adverse effects compared to conventional chemotherapy.

How to take Crizotinib 250 mg

Crizotinib 250 mg should be taken exactly as prescribed by your oncologist. Usually, the dosage involves oral intake twice daily, approximately 12 hours apart. It is best taken with water and can be consumed with or without food.

Patients should swallow the tablets whole without crushing or chewing. Consistency is critical, so adhere closely to the dosing schedule to maintain optimal medicine levels in the body.

Do not alter your dose or discontinue treatment without consulting your healthcare provider, as this may affect treatment effectiveness. If you miss a dose, take it as soon as you remember unless it is near the time for your next dose; never double dose.

Benefits of Crizotinib 250 mg

• Targets specific genetic mutations in NSCLC, providing personalized therapy
• May slow cancer progression and reduce tumor size
• Oral administration offers convenience compared to intravenous treatments
• Generally well tolerated with manageable side effects
• Helps improve quality of life by targeting cancer cells selectively

Dosage and Administration

The typical dosage of Crizotinib 250 mg is one 250 mg tablet taken twice daily. The exact dose and duration depend on the patient’s condition, stage of cancer, and response to therapy.

Regular monitoring through clinical check-ups, imaging, and lab tests are essential to evaluate treatment efficacy and detect any side effects early. Adjustments to dosage may be made by the prescribing doctor based on tolerance and therapeutic outcomes.

Who Should Use Crizotinib 250 mg?

Crizotinib 250 mg is suitable for adult patients diagnosed with non-small cell lung cancer that tests positive for ALK or ROS1 gene rearrangements. Before starting treatment, confirmatory genetic testing is mandatory to ensure the medicine’s appropriateness.

This medication is prescribed when the cancer is locally advanced or has metastasized, and conventional therapies are either insufficient or unsuitable.

Who Should Avoid Crizotinib 250 mg?

Patients with a known allergy to Crizotinib or any other ingredients in the formulation should avoid this medicine. It is not recommended for individuals without ALK or ROS1 positive NSCLC.

Use caution if you have liver or kidney impairment; discuss your full medical history with your doctor. Pregnant or breastfeeding women should avoid Crizotinib unless advised by a specialist.

Side Effects of Crizotinib 250 mg

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Fatigue
• Swelling of hands and feet
• Blurred vision
• Elevated liver enzymes
• Breathing difficulties
• Increased heart rate
• Decreased appetite
• Headache
• Fever

Safety Advice

• Inform your doctor about all medical conditions before starting treatment
• Report any unusual symptoms or side effects promptly
• Do not consume grapefruit or grapefruit juice during treatment
• Avoid driving or operating machinery if experiencing visual disturbances
• Regular blood tests are required to monitor liver function and blood counts
• Complete the full course as directed, even if you feel better
• Do not share this medication with others

Drug Interactions

• Medications metabolized by CYP3A4 enzyme may interact
• Strong CYP3A4 inhibitors or inducers should be avoided
• Other anticancer drugs may increase side effects
• Consult your doctor before taking any new medicines or supplements

Storage Instructions

Store Crizotinib 250 mg tablets in a cool, dry place away from direct sunlight. Keep the container tightly closed and out of reach of children. Avoid storing in bathrooms or areas with high humidity.

Always check the expiry date before use and never use the medication if it appears discolored or damaged.

Where to buy Crizotinib 250 mg in Malaysia?

Crizotinib 250 mg is available for purchase at licensed pharmacies and oncology treatment centers in Malaysia. It is crucial to buy this medicine from authorized sellers to ensure authenticity and proper storage.

Patients may also obtain Crizotinib through hospital pharmacies upon medical prescription. Online purchases are possible but should be limited to verified and reputable pharmacy websites.

Frequently Asked Questions (FAQ)

What is the price of Crizotinib 250 mg in Malaysia?

The price may vary depending on the pharmacy and region; it is advisable to consult local vendors or hospital pharmacies for the latest pricing information.

What happens if I miss a dose?

If you miss a dose, take it as soon as you remember unless it is nearly time for your next scheduled dose. Do not take two doses simultaneously. Contact your doctor if you are unsure.

Where can I find Crizotinib 250 mg for sale?

You can find Crizotinib 250 mg at certified pharmacies, hospital pharmacies, and authorized online drugstores in Malaysia. Ensure you have a valid prescription before purchasing.

Is Crizotinib 250 mg available in Malaysia?

Yes, Crizotinib 250 mg is available in Malaysia through licensed pharmacies and oncology treatment centers.

Can I take Crizotinib 250 mg with other medications?

Crizotinib may interact with several medicines. Always inform your healthcare provider about all drugs and supplements you are taking to avoid harmful interactions.

Is Crizotinib 250 mg safe during pregnancy?

Crizotinib is not recommended during pregnancy unless prescribed by your doctor. Effective contraception should be used during treatment and for several months after.

How long does it take for Crizotinib 250 mg to work?

Response times vary, but some patients may see changes within weeks. Regular evaluation by your oncologist will determine treatment effectiveness.

Conclusion

Crizotinib 250 mg is a vital treatment option for patients with specific genetic types of non-small cell lung cancer. Its targeted action helps manage the disease effectively with a manageable safety profile. When used under medical supervision, it offers hope for improved disease control and patient quality of life. Patients in Malaysia can access authentic Crizotinib 250 mg through licensed healthcare providers to ensure safe and effective cancer care.